Show simple item record

dc.contributor.authorSemple, Fen_US
dc.contributor.authorWebb, Sen_US
dc.contributor.authorLi, HNen_US
dc.contributor.authorPatel, HBen_US
dc.contributor.authorPerretti, Men_US
dc.contributor.authorJackson, IJen_US
dc.contributor.authorGray, Men_US
dc.contributor.authorDavidson, DJen_US
dc.contributor.authorDorin, JRen_US
dc.date.accessioned2017-10-10T08:24:58Z
dc.date.issued2010-04en_US
dc.date.submitted2017-06-08T08:57:14.630Z
dc.identifier.issn0014-2980en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/27304
dc.description.sponsorshipKay Samuel, New Royal Infirmary Edinburgh, UK. School of Chemistry, University of Edinburgh, UK MRC. EPSRC (J.R.D.). ARC (M.G.). Wellcome Trust Research Career Development Fellow. Grant Number: ♯ 078265.en_US
dc.format.extent1073 - 1078en_US
dc.language.isoenen_US
dc.relation.ispartofEUR J IMMUNOLen_US
dc.subjectAnti-inflammatoryen_US
dc.subjectcAMPen_US
dc.subjectDefensinen_US
dc.subjectTNF-alphaen_US
dc.subjectANTIMICROBIAL PEPTIDE LL-37en_US
dc.subjectHUMAN BETA-DEFENSIN-3en_US
dc.subjectCOPY NUMBERen_US
dc.subjectINDUCIBLE PEPTIDEen_US
dc.subjectGENE-CLUSTERen_US
dc.subjectRECEPTORen_US
dc.subjectINNATEen_US
dc.subjectINTERLEUKIN-10en_US
dc.subjectINFLAMMATIONen_US
dc.subjectMODULATIONen_US
dc.titleHuman beta-defensin 3 has immunosuppressive activity in vitro and in vivoen_US
dc.typeArticle
dc.identifier.doi10.1002/eji.200940041en_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.volume40en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record